Tag: Research
-
Uncovering Racial Differences in Genomic Profiles of Prostate Cancer
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
-
Novel Drug May Increase Bone Growth in Children with Achondroplasia
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
-
Antibiotic Treatment for Appendicitis Shows Similar Patient Outcomes as Surgery
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
-
Utilizing B-Cells to Promote Glioblastoma Immunity
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
-
Source of Rare Intellectual Disability Syndrome Discovered
New findings have revealed previously unknown information about the genetic basis for Armfield XLID syndrome, a rare intellectual disability linked to genetic defects in the X chromosome.
-
Inflammation Linked to Alzheimer’s
A new study provides a missing link between inflammation and protein deposits that contribute to Alzheimer’s disease.
-
New Details on T-Cell Methylation
The DNA methylation landscape of regulatory T-cells is more complex than previously understood, according to a new Northwestern Medicine study.
-
‘Snowflake’ Nanoparticle Boosts Cancer Therapy
A snowflake-shaped nanoparticle greatly enhanced the combination of radiotherapy and immunotherapy in mouse models of prostate cancer.
-
Drug May Delay Progression of Ovarian Cancer
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
-
New Chemotherapy Alternative for Lymphoma
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
